Japan approves AI software that uses MRI scans to identify depression, aiming to make diagnosis more objective.
Key Details
- 1AI algorithm detects signs of depression by analyzing MRI brain scans.
- 2Developed by the Advanced Telecommunications Research Institute International in Japan.
- 3Software provides visual evidence of brain activity alterations linked to depression.
- 4Regulatory approval granted in Japan; type not specified (likely a medical device approval).
- 5Conventional depression diagnoses typically rely on subjective patient reports and interviews.
Why It Matters
Objective tools for diagnosing depression could improve accuracy, standardization, and treatment selection in mental health care. The approval highlights expanding clinical roles for imaging AI, especially in neuropsychiatric applications.
Source
Health Imaging
Related News
•Radiology Business
Lucida Medical Raises $11M for AI-Based Prostate MRI Diagnosis Expansion
Lucida Medical, specializing in AI-assisted prostate cancer diagnosis via MRI, raises $11.4M to drive US FDA approval and platform expansion.
•AuntMinnie
AI Models Reveal Racial Disparities in Breast Cancer Patterns
Machine learning models reveal significant racial disparities and key predictors in breast cancer incidence across diverse groups.
•Radiology Business
UCLA Appoints Inaugural Associate Dean for Health AI Strategy
UCLA has appointed Katherine P. Andriole as its first associate dean for Health AI Strategy and Innovation, with an initial focus on radiology.